abstract |
The invention provides nucleic acid molecules encoding mutant FGF21 polypeptides, mutant FGF21 polypeptides, as such, pharmaceutical compositions comprising mutant FGF21 polypeptides, and methods for treating metabolic diseases using such nucleic acids, polypeptides or pharmaceutical compositions. |